SWEDEPAD 2: the debate is not over yet!

The debate isn’t over.. and neither is your chance to watch it!

If you didn’t get the opportunity to follow it live, or simply want to revisit the discussion, don’t miss the very first PVI webinar, dedicated to this much-talked-about trial, as the replay is now available!

Join our Course Directors Yann Gouëffic and Koen Deloose, together with their outstanding guests Joakim Nordanstig, one of the study’s leading investigators, and Eric Secemsky, a recognised expert in the field.

During the webinar, the experts discussed key aspects of the SWEDEPAD 2 trial, including what makes a study pragmatic, the concept of registry-based RCTs, and how linkages with national patient and mortality registers work. 

They explored the role of patient-reported outcomes (PROMs) in claudication assessment, and the debate around surrogate versus clinical endpoints. 

Other topics included the impact of lesion type, the consideration of class effects for DES/DCB, and how these results may influence daily practice, healthcare recommendations, and the design of future studies.

Eager to learn more? Log in or create your PVI account to watch the full video!